Plain-English translation of NCT06899204 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This study is observing how well works for people with moderate-to-severe eczema (atopic dermatitis) who have tried other biologic medications without success. Researchers at about 15 U.S. clinics will track your skin improvement and how you feel over time while taking this medication. The goal is to understand how effective this treatment is for people like you in everyday medical practice, not just in controlled research settings.
Many people with severe eczema don't get enough relief from the first or second biologic medications they try. There isn't yet enough real-world information about how this newer medication performs for these patients, so this study aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
You would continue taking as your dermatologist prescribed, and visit the clinic regularly to have your skin assessed and fill out questionnaires about how your eczema is responding and how the treatment affects your daily life. The study will follow you over approximately one year to gather real-world information about the medication's effectiveness. There is no experimental drug to take — you're already receiving this medication as part of your regular care, and the study simply documents how it works for you.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States